Bond.az White LogoBond.az Black Logo

Home Depot Q1 2026 earnings beat forecasts, stock dips

Home Depot Q1 2026 earnings beat forecasts with EPS of $3.43 and revenue of $41.8B. Stock dips 2.49% amid margin concerns.

Sophia Anderson
BySophia Anderson- Senior Editor
|
0

Home Depot Inc. reported its financial results for the first quarter of 2026, surpassing analyst expectations with an adjusted EPS of $3.43, slightly above the forecast of $3.41. Revenue hit $41.8 billion, exceeding expectations of $41.51 billion.

Despite the positive results, Home Depot's stock fell 2.49% in premarket trading to $292.35, reflecting investor concerns about future growth and margin pressures. The company's overall sales grew 4.8% year-over-year, driven by a 0.6% increase in comparable store sales.

CEO Ted Decker emphasized the company's ability to gain market share through customer service and strategic investments. CFO Richard McPhail highlighted the impact of the GMS acquisition on margins but expressed confidence in achieving long-term financial targets.

More News
Today / 14:40
|
851

Vallourec Q1 2026 Beats Forecasts, Stock Fluctuates

Vallourec Q1 2026 earnings beat forecasts; stock sees volatility. Strong EBITDA and cash flow highlight performance.

0
Today / 14:03
|
352

Hera Group Q1 2026: Steady growth

Hera Group posts steady growth in Q1 2026 with net profit of EUR 155 million and EPS of $0.105.

0
Today / 14:02
|
259

Oxford Lane Capital NAV drops, stock dips

Oxford Lane Capital Corp reports Q4 FY2026 results: NAV per share down, stock falls 4.03%. CLO yields decline. Read more on challenges and outlook.

0
Today / 13:43
|
246

Driven Brands Q4 2025 Revenue Growth Reported

Driven Brands Q4 2025 revenue grows 7.7% to $460.1M, EPS $0.34. Stock up 1.12%.

0
Today / 13:41
|
777

Ceragon Q1 2026 Revenue Beats Estimates

Ceragon Networks Q1 2026 revenue beat estimates at $85M. EPS $0.01. Stock rose 6.77% premarket. Full-year guidance reiterated.

0
Today / 13:10
|
739

Fractyl Health Q1 2026 EPS Beat, Shares Surge 23%

Fractyl Health Q1 2026 EPS beat expectations by 76%, shares surged 23% after hours. Revita program data expected in Q4 2026.

0
Today / 13:01
|
272

Antalpha Q1 2026: EPS Misses Forecast, Stock Rises

Antalpha Q1 2026: EPS misses forecast at $0.07, stock rises 2.42%. Revenue up 52% to $20.7M. Web3 AI agent Nina launched. Q2 guidance $11M-$13M.

0
Today / 12:44
|
314

GNFC Q4 profit surges, stock climbs 5.17%

GNFC Q4 FY2026 strong results: revenue up 11%, PAT up 35%, stock rises 5.17%. Chemical segment drives growth.

0
Today / 12:42
|
677

Relmada TX Q1 2026: Loss and stock dip

Relmada Therapeutics Q1 2026 results: stock declines, strong cash position and NDV-01 program in focus.

0
Today / 12:00
|
959

Inovio Beats Q1 2026 EPS Forecast, Stock Slips

Inovio Q1 2026 EPS beats forecasts, but stock falls. Detailed financial analysis and outlook on Bond.az.

0
Today / 11:50
|
449

CytoSorbents Q1 2026 Misses Forecasts, Stock Falls

CytoSorbents Q1 2026 results: EPS of -$0.05 misses estimate, revenue of $8.9M falls short, stock drops 7.53%. Company cuts costs and targets breakeven in H2 2026.

0
Today / 10:53
|
859

IOC Q4 2026 earnings beat expectations

IOC Q4 2026 earnings beat expectations with EPS of 6.15, a 20.59% surprise. Stock rose 2.42%. Record refining throughput and 184% profit growth reported.

0
...